Navigation Links
Obesity-linked high blood volumes render PSA prostate cancer test less effective, study suggests
Date:11/20/2007

The extra blood volume produced in the obese may so dilute levels of a telltale protein produced by prostates that the popular PSA test may be essentially useless for diagnosing prostate cancer in men carrying extra pounds, a new study in The Journal of the American Medical Association suggests.

The new research, combining data from more than 13,000 prostate cancer patients at The Johns Hopkins Hospital and elsewhere, could eventually affect the reliability of scores of other blood tests for cancer and other diseases in obese people, or at least alter the way those tests are analyzed, investigators say.

The predictive value of the PSA test depends on accurate readings of a protein, (P)rostate (S)pecific (A)ntigen continually pumped out by the prostate. When the prostate is enlarged - due to cancer or other disorders - the concentration of PSA in the bloodstream can increase, signaling the possible presence of a tumor. Physicians thus commonly regard increased PSA values as a first marker to diagnose prostate cancer, to be followed by other diagnostic tests such as physical exams and ultrasound.

Complicating the picture further, the researchers note, that both physical exams and imaging studies are more difficult in obese men.

Although recent studies have shown that PSA concentrations can be lower than expected in obese men with prostate cancer, the current research was designed to determine which of two dueling hypotheses explained this, notes Alan Partin, M.D., chief of the Department of Urology at Johns Hopkins Brady Urological Institute.

One idea was based on the possibility that obese men make less PSA because they tend to have less testosterone, the sex hormone that prompts PSA production. The other attributed the phenomenon to the increased amount of blood that obese men produce to support their size, which has the effect of thinning out the concentration of PSA.

Partin and Stephen Freedland, M.D., Partins former postdoctoral fellow who is now an assistant professor at Duke University, investigated both ideas by assessing how much total PSA obese and normal-weight men have.

Using records of patients treated for prostate cancer between 1988 and 2006 at The Johns Hopkins Hospital, Duke University and various Veterans Affairs hospitals, Partin, Freedland and their colleagues compiled information on PSA concentration and body mass index (BMI), a ratio of body weight to height that generally indicates whether someone is underweight, normal weight or overweight.

Using a standard calculation, the researchers used BMIs to estimate the amount of blood circulating in each patients body. A different calculation used this blood volume, along with PSA concentrations, to estimate the total amount of PSA each patient had.

As expected, PSA concentrations were typically lower in the obese patients than in the normal-weight ones, although the total amount of PSA was about the same in both groups of patients.

Its clear to us that excess blood had diluted PSA concentrations in that group, says Partin.

Freedland says a variety of new tests currently in development for cancer and other diseases rely on the concentrations of disease markers similar to PSA circulating in the blood. For these other tests just starting down the development pipeline, he says, we need to think about the actual total amount of a biological marker rather than concentration.


'/>"/>

Contact: Christen Brownlee
cbrownlee@jhmi.edu
410-955-7832
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: